Strides Shasun has completed the United States Food & Drug Administration (USFDA) inspection at its Bangalore facility. The company has been issued a Form 483 with 3 observations. None of these observations relate to data integrity and quality control. The company will address these observations comprehensively.

Total volume of shares traded on the bourses today was lower by 5.50% to 286,685 compared with 22-day average volume of 303,362.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.

Shares of the company declined Rs 17.75, or 1.93%, to trade at Rs 900.00 at the BSE (9.03 a.m., Monday).